Microdosing GLP-1 Receptor Agonists During Perimenopause: A Clinical Approach to Hormonal Weight Gain Written and edited by Sarah Bonza MD, MPH, FAAFP, MSCP, DipABLM, NBC-HWC Perimenopause represents a challenging time for women, with up to 70% experiencing weight gain due to declining estrogen levels, decreased energy expenditure, and metabolic changes
Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis
IVY RX states that all affiliated providers are board-certified, US-licensed healthcare professionals
LIPID METABOLISM AND HEPATIC THYROID HORMONE ACTION TH action modulates the lipolysis of fat stores from white adipose tissue, which generates circulating free fatty acids (FFAs), the major source of lipids for the liver
The process, though, is agonizingly slow
Is intranasal Dihexa more effective than oral administration